Results 111 to 120 of about 92,970 (328)

Quality‐adjusted life years in the presence and absence of organized mammographic screening using data from BreastScreen Norway

International Journal of Cancer, EarlyView.
What's New? Although mammographic screening can reduce breast cancer mortality and extend life, some studies have found a negative impact on net quality‐adjusted life years (QALYs). Here, the authors estimated net QALYs associated with biennial mammographic screening for women aged 50–69 years in Norway under various scenarios.
Rick Groeneweg, Nicolien T. van Ravesteyn, Lindy M. Kregting, Giske Ursin, Solveig Hofvind, Nataliia Moshina   +5 more
wiley   +1 more source

Ductal carcinoma in situ

, 2017
Ductal carcinoma in situ (DCIS) represents some 25% of screen-detected breast neoplasia. Established clinical practice includes surgery, radiotherapy and endocrine therapy, to reduce the likelihood of DCIS recurrence or progression to invasive breast cancer.
Stacey A. Carter, Sarah E. Pinder, Alastair M. Thompson   +2 more
openaire   +2 more sources

Challenges in the future of cancer screening

International Journal of Cancer, EarlyView.
Abstract The purpose of cancer screening is to reduce mortality, and ideally incidence, from the cancer screened for. Until recently, cancer screening has been offered to all persons in pre‐defined sex‐ and age‐groups. The exception is lung screening which is targeted to high‐risk individuals.
Elsebeth Lynge, Berit Andersen, Stig E. Bojesen, Lone Kjeld Petersen, Mickael Bech, Martin Bøgsted, Mie Seest Dam, Søren Egstrand, Anne Mette Fløe Hvass, Camilla J. Kobylecki, Kristina Lång, Mads Nielsen, Giorgi Paolo Rossi, Michael Stenger, Ilse Vejborg, Future of Cancer Screening Working Group, Vibe Munk Bertelsen, Janne Bigaard, Karen Omann Binderup, Lennart Friis‐Hansen, Stine Bisgaard Greve, Jessica Xin Hjaltelin, Rikke Hedegaard Jensen, Gitte Jessing, Pia Kirkegaard, Mette Hartmann Nonboe, Tina Bech Olesen, Katrine Stolberg, Signe Bülow Therkildsen, Mette Kielsholm Thomsen   +29 more
wiley   +1 more source

DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer [PDF]

, 2015
Kevin C. Johnson, Devin C. Koestler, Thomas Fleischer, Panpan Chen, Erik G. Jenson, Jonathan D. Marotti, Tracy Onega, Vessela N. Kristensen, Brock C. Christensen   +8 more
openalex   +1 more source

Ductal Carcinoma In Situ in Pregnant Women

, 2021
Akiko Chiba, Emily E. Bunce
openalex   +1 more source

Lymph‐based liquid biopsy: Current progress and future potential

Interdisciplinary Medicine, EarlyView.
Recent evidence under the revised Starling principle indicates that lymph‐based liquid biopsies may offer superior diagnostic performance over blood‐based counterparts in certain clinical scenarios, such as early‐stage solid tumor detection. Currently, various biomarkers within the lymphatic system show significant diagnostic potential for a range of ...
Dongdong Liu, Leheng Cheng, Xiaolin Hu, Sergio Bernardini, Hong Zhang, Ling Zhu, Yang Luo   +6 more
wiley   +1 more source

Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast. [PDF]

, 2019
Rates of positive margins after surgical resection of invasive lobular carcinoma (ILC) are high (ranging from 18 to 60%), yet the efficacy of re-excision lumpReceptor subtypeectomy for clearing positive margins is unknown.
Alvarado, Michael, Esserman, Laura J, Ewing, Cheryl, Fahrner-Scott, Kelly, Mukhtar, Rita A, Piper, Merisa L, Wong, Jasmine   +6 more
core  

No Ink on Ductal Carcinoma In Situ: A Single Centre Experience [PDF]

, 2018
Piero Fregatti, Marco Gipponi, Francesca Depaoli, Federica Murelli, M. Guenzi, Elisabetta Bonzano, Marcello Ceppi, Daniele Friedman   +7 more
openalex   +1 more source

Application of Multimodal Ultrasound Combined With BI‐RADS in Classification and Diagnosis of Non‐Mass Breast Lesions

Journal of Clinical Ultrasound, EarlyView.
This study demonstrates that integrating microvascular flow imaging, shear wave elastography, and contrast‐enhanced ultrasound with the BI‐RADS classification significantly improves the diagnostic accuracy for non‐mass breast lesions, offering a more reliable tool for differentiating benign from malignant findings.
Zengdi Yang, Yongyan Lyu, Yanting Yang, Cuiping Xu, Keke Zhang, Xuxu Yang, Feng Chen, Lanlan Cheng, Minglei Ren   +8 more
wiley   +1 more source

Complete Regression of Ductal Carcinoma in Situ Following Chemotherapy and Trastuzumab: Should we Rethink Management? [PDF]

, 2015
Robert O. Dillman
openalex   +1 more source